Find link

language:

Find link is a tool written by Edward Betts.

searching for ROS1 22 found (144 total)

alternate case: rOS1

ALK inhibitor (1,951 words) [view diff] exact match in snippet view article find links to article

response of the tumour and prognosis of the patient. Crizotinib (also a ROS1 and c-MET inhibitor) was approved in Aug 2011 by the US FDA for ALK-positive

Merestinib (157 words) [view diff] exact match in snippet view article find links to article

several other receptor tyrosine kinases such as MST1R, FLT3, AXL, MERTK, TEK, ROS1, NTRK1/2/3, and DDR1/2. Meristinib is part of a phase II clinical trial for

Mosunetuzumab (758 words) [view diff] exact match in snippet view article find links to article

Entrectinib (ALK, ROS1, NTRK), Futibatinib (FGFR2), Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib

Sanbot (robot) (888 words) [view diff] exact match in snippet view article

Laser: 1920 x 720 HD wide gamut output: 60 Hz Aspect-ratio: 16:9 Platform ROS1.1 Sound Voice control, 360 degree sound localization 2 x tweeter, 1 x woofer

RNA-directed DNA methylation (14,822 words) [view diff] exact match in snippet view article find links to article

repression, this is not the case at the ROS1 locus. Instead, methylation of the helitron TE promotes ROS1 expression, so ROS1 expression is lost in mutants of

Open-source robotics (1,432 words) [view diff] exact match in snippet view article find links to article

the robot operating system, now as version 2. Other alternatives include ROS1, YARP — used in the iCub, URBI, and Orca. Most robot sensors and actuators

RNA polymerase IV (1,821 words) [view diff] exact match in snippet view article find links to article

Claudine; Tourmente, Sylvette (2008-12-01). "Interplay of RNA Pol IV and ROS1 During Post-Embryonic 5S rDNA Chromatin Remodeling". Plant and Cell Physiology

Cemiplimab (1,060 words) [view diff] exact match in snippet view article find links to article

adults with advanced non-small cell lung cancer (NSCLC) with no EGFR, ALK, or ROS1 aberrations. As of 2017[update], cemiplimab is being investigated for the

Jian-Kang Zhu (2,374 words) [view diff] exact match in snippet view article find links to article

discovered the Arabidopsis 5-methylcytosine DNA glycosylase/lyase ROS1 in 2002. ROS1 is the first DNA demethylase (the enzyme initiating active DNA demethylation)

MAS1 (717 words) [view diff] case mismatch in snippet view article find links to article

Birnbaum D, Young D, Birchmeier C, Wigler M, Ruddle FH (Jul 1987). "Human ros1 and mas1 oncogenes located in regions of chromosome 6 associated with tumor-specific

Jian-Kang Zhu (2,374 words) [view diff] exact match in snippet view article find links to article

discovered the Arabidopsis 5-methylcytosine DNA glycosylase/lyase ROS1 in 2002. ROS1 is the first DNA demethylase (the enzyme initiating active DNA demethylation)

Selpercatinib (2,263 words) [view diff] exact match in snippet view article find links to article

et al. (April 2020). "New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)". Current Oncology Reports. 22 (5): 48. doi:10.1007/s11912-020-00909-8.

Robot Operating System (5,540 words) [view diff] exact match in snippet view article find links to article

from a communal database called the parameter server. A process called the ROS1 Master makes all of this possible by registering nodes to itself, setting

DNA glycosylase (4,056 words) [view diff] exact match in snippet view article find links to article

Kapoor, A; Zhu, J-K (2006). "Role of the Arabidopsis DNA glycosylase/lyase ROS1 in active DNA demethylation". Proc. Natl. Acad. Sci. U.S.A. 103 (31): 11796–11801

Roche (5,738 words) [view diff] exact match in snippet view article find links to article

Rohypnol (flunitrazepam), for severe insomnia. Rozlytrek (entrectinib), for ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumours

Elranatamab (821 words) [view diff] exact match in snippet view article find links to article

Entrectinib (ALK, ROS1, NTRK), Futibatinib (FGFR2), Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib

ETV6-NTRK3 gene fusion (1,117 words) [view diff] exact match in snippet view article find links to article

usefulness in these cancers. Entrectinib is a pan-NTRK as well as an ALK and ROS1 tyrosine kinase inhibitor has been found useful in treating a single patient

Melanoma (16,312 words) [view diff] exact match in snippet view article find links to article

include fusions involving various kinases such as BRAF, RAF1, ALK, RET, ROS1, NTRK1., NTRK3 and MET BRAF, RAS, and NF1 mutations and kinase fusions are

Christine Lovly (792 words) [view diff] exact match in snippet view article find links to article

by OncoDaily. Her publications include: Lovly, Christine (2012-03-10). "ROS1 rearrangements define a unique molecular class of lung cancers". Journal

RET inhibitor (2,041 words) [view diff] exact match in snippet view article find links to article

achieved by selective inhibitors in other kinase fusions such as ALK or ROS1, these molecules offered much more limited clinical benefit, which highlighted

Neil Vasdev (1,822 words) [view diff] exact match in snippet view article find links to article

"Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib". Nature Communications. 8 (1): 15761. Bibcode:2017NatCo

Sugemalimab (912 words) [view diff] exact match in snippet view article find links to article

metastatic non-small cell lung cancer with no sensitising EGFR mutations, or ALK, ROS1 or RET genomic tumor aberrations. Sugemalimab is a fully human monoclonal